HIPAA Compliance for Allergy and Immunology Practices

Allergy and immunology practices carry a HIPAA profile that looks calm on the surface and is surprisingly demanding underneath. These are usually outpatient practices, but they build some of the longest-running, most detailed records in medicine: skin-test panels, specific IgE lab results, and years of allergen immunotherapy visits. They also see a steady stream of pediatric patients and run high-frequency injection clinics where the same patients come back weekly. Those traits, longevity, pediatrics, and a busy front office, are where allergy and immunology compliance becomes specific.

What’s Distinct About HIPAA for Allergy and Immunology

Immunotherapy is the defining workflow. Allergen extract vials are patient-specific, labeled with identifying information, and stored and handled in a clinical area that many people pass through. Build-up and maintenance schedules bring patients in repeatedly, so check-in screens, sign-in sheets, and vial labels can leak protected health information dozens of times a day if the front office is not designed carefully. Add to that the heavy pediatric mix, which means constant decisions about parental access and personal representatives, and the long retention of allergy histories, and you have a practice where access control and physical safeguards matter more than the modest size suggests.

The Security Risk Analysis Requirement

Like every covered entity, an allergy and immunology practice must “conduct an accurate and thorough assessment of the potential risks and vulnerabilities to the confidentiality, integrity, and availability” of electronic protected health information under 45 CFR § 164.308(a)(1)(ii)(A). For this specialty, the analysis should pay particular attention to the immunotherapy area and front office: who can view schedules and patient lists, how vial labels and check-in displays are positioned, and how lab interfaces move specific IgE results between systems. The risk analysis is the document that proves you looked at these specific exposures and addressed them.

Because allergy practices field frequent records requests from parents and other providers, a clear right of access process is also essential, so staff verify personal representatives correctly before releasing a minor’s history.

The Proposed 2026 Security Rule Update

In December 2024, the Office for Civil Rights published a Notice of Proposed Rulemaking that would strengthen the HIPAA Security Rule. It would end the “addressable” category, making safeguards like encryption and multi-factor authentication effectively required, and it would demand more thorough inventories and more frequent risk reviews. This is a proposed rule, not final law. If it is finalized, organizations would have a 240-day compliance window once it is published. For allergy and immunology practices, the message is to formalize the controls around your scheduling, lab, and immunotherapy systems now rather than later.

How Medcurity Helps

Medcurity guides allergy and immunology practices through a complete Security Risk Analysis, helps you document administrative, physical, and technical safeguards, and keeps everything audit-ready. Pricing starts at $499/year (about $42/month) for a single practice, and larger groups can request a quote. Pair the platform with our HIPAA compliance checklist to keep your front office and immunotherapy workflows consistently protected.

Frequently Asked Questions

Is allergy testing and immunotherapy data treated differently under HIPAA?

It is protected health information like any other clinical data, but allergy and immunology practices accumulate unusually rich longitudinal records: skin-test results, specific IgE labs, and years of immunotherapy visits. The volume and the long retention period raise the stakes for access control and secure storage, even though the underlying rules are the same.

How does the right of access apply to pediatric allergy patients?

Most allergy practices see a large share of children. Under the HIPAA right of access, a parent or guardian is usually the personal representative who can access a minor’s records, with state law and specific exceptions governing the edges. Your front-desk and records staff should know how to verify a representative before releasing a child’s allergy and immunotherapy history.

Do we need Business Associate Agreements with our allergy lab and EHR vendors?

Yes, when a vendor handles protected health information on your behalf. Reference labs running specific IgE panels, your electronic health record host, and any immunotherapy management or scheduling software are business associates and need an agreement before you exchange data. Sending results to a referring physician for treatment is a permitted disclosure that does not require one.

What is the biggest compliance gap in a typical allergy practice?

Frequent in-office immunotherapy visits create a high-traffic front office where schedules, vial labels, and check-in screens can expose patient names and details. Combined with staff who often span scheduling, injections, and billing, the most common gap is over-broad access plus casual exposure of protected health information at the point of care.